Tate & Lyle PLC
Director Shareholding
The Trustees of the Tate & Lyle PLC Employee Benefit Trust (Number 1) (the
'EBT') notified the Company on 15 June 2004 that on 15 June 2004 it had bought
375,000 Tate & Lyle PLC ordinary shares at an average price of
322.59 pence per share.
By virtue of their interests in the Tate & Lyle 2000 Executive Share Option
Scheme and the Tate & Lyle 2003 Performance Share Plan, the Executive Directors
of Tate & Lyle PLC (Iain Ferguson, Stanley Musesengwa, Simon Gifford and Stuart
Strathdee) are potential beneficiaries of the EBT and are thus deemed to have
become interested in the above shares.
Following this transaction, the EBT owns 12,564,153 ordinary shares in Tate &
Lyle PLC.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.